ROPN1 Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association
<i>ROPN1</i> overexpression in TNBC/basal-like tumors suggests a role as a prognostic biomarker and predictor of post-chemotherapy resistance. Investigation of <i>ROPN1</i> expression in breast tumors may lead to alternative strategies targeting pro-metastatic pathways and improve precision treatment for aggressive breast cancer.
Authors
- Daniel Rodrigues de Bastos (ORCID: https://orcid.org/0000-0001-7091-1959)
- Ricardo Cesar Cintra (ORCID: https://orcid.org/0000-0002-5374-5319)
- Andrés Galindo Céspedes (ORCID: https://orcid.org/0000-0003-3277-1996)
- Olinda María Higinia Gamarra Rojas (ORCID: https://orcid.org/0000-0002-3532-326X)
- Carlos Javier Melgarejo (ORCID: https://orcid.org/0000-0001-5055-3285)
Institutions
- Instituto do Câncer do Estado de São Paulo (BR)
- Hospital Nacional Cayetano Heredia (PE)
- Universidad Católica Santo Toribio de Mogrovejo (PE)
- Universidad Nacional Pedro Ruíz Gallo (PE)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Universidad Privada del Este (PY)
Publication Details
- Journal
- European Journal of Breast Health
- Published
- 2025-09-04
- DOI
- https://doi.org/10.4274/ejbh.galenos.2025.2025-6-2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00